Post-brushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: The Papanicolaou Society of Cytopathology Guidelines

CytoJournal

Volumn 11, Issue SUPPL. 1, 2014, Pages 40-48

  Kurtycz, Daniel F I ^a   Field, Andrew ^b   Tabatabai, Laura ^c   Michaels, Claire ^d   Young, Nancy ^e   Schmidt, C Max ^f   Farrell, James ^g   Gopal, Deepak ^a   Simeone, Diane ^h   Merchant, Nipun B ⁱ   Pitman, Martha Bishop ^j  

^a University of Wisconsin Richland   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f INDIANA UNIVERSITY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ VANDERBILT UNIVERSITY   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Cytology; guidelines; management; pancreas; Papanicolaou Society of Cytopathology; treatment

Indexed keywords

CA 19-9 ANTIGEN; FLUOROURACIL; GEMCITABINE; PACLITAXEL; QUINOLONE DERIVATIVE; SOMATOSTATIN DERIVATIVE;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ARTICLE; AUTOIMMUNE PANCREATITIS; BILIARY TRACT DISEASE; BREAST CARCINOMA; CHOLESTASIS; CHRONIC PANCREATITIS; COMMON BILE DUCT; CONSERVATIVE TREATMENT; CYTODIAGNOSIS; CYTOLOGY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; GENETIC SCREENING; GERMLINE MUTATION; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LAPAROSCOPY; LIVER FUNCTION TEST; LYMPHOMA; MALIGNANT TRANSFORMATION; MUCINOUS CYSTIC NEOPLASM; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATIC NEUROENDOCRINE TUMOR; PRACTICE GUIDELINE; PSEUDOCYST; RECURRENCE RISK; REPEAT PROCEDURE; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CYTOLOGY;

EID: 84906993960     PISSN: 09745963     EISSN: 17426413     Source Type: Journal    
DOI: 10.4103/1742-6413.133356     Document Type: Article

References (57)

1. Elek G, Gyökeres T, Schäfer E, Burai M, Pintér F, Pap A. Early diagnosis of pancreatobiliary duct malignancies by brush cytology and biopsy. Pathol Oncol Res 2005;11:145-55.
2. Eloubeidi MA, Jhala D, Chhieng DC, Chen VK, Eltoum I, Vickers S, et al. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer 2003;99:285-92.
3. Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, Imrie CW, et al. Brush cytology in the assessment of pancreatico-biliary strictures: A review of 406 cases. J Clin Pathol 2001;54:449-55.
4. Kocjan G, Rode J, Lees WR. Percutaneous fine needle aspiration cytology of the pancreas: Advantages and pitfalls. J Clin Pathol 1989;42:341-7.
5. Chong I, Cunningham O. Pancreatic Cancer. In: Longo O, editor. Harrison's Principles of Internal Medicine. 19th ed. New York, NY: McGraw Hill; 2012.p. 786-9.
6. Spier BJ, Johnson EA, Gopal DV, Frick T, Einstein MM, Byrne S, et al. Predictors of malignancy and recommended follow-up in patients with negative endoscopic ultrasound-guided fine-needle aspiration of suspected pancreatic lesions. Can J Gastroenterol 2009;23:279-86.
7. Wani S, Gupta N, Gaddam S, Singh V, Ulusarac O, Romanas M, et al. A comparative study of endoscopic ultrasound guided fine needle aspiration with and without a stylet. Dig Dis Sci 2011;56:2409-14.
8. Gimeno-Garcia AZ, Elwassief A. How to improve the success of endoscopic ultrasound guided fine needle aspiration cytology in the diagnosis of pancreatic lesions. J Interv Gastroenterol 2012;2:31-6.
9. Noh KW, Wallace MB. Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic adenocarcinoma. MedGenMed 2005;7:15.
10. Suzuki R, Lee JH, Krishna SG, Ramireddy S, Qiao W, Weston B, et al. Repeat endoscopic ultrasound-guided fine needle aspiration for solid pancreatic lesions at a tertiary referral center will alter the initial inconclusive result. J Gastrointestin Liver Dis 2013;22:183-7.
11. Gagovic V, Spier BJ, DeLee RJ, Barancin C, Lindstrom M, Einstein M, et al. Endoscopic ultrasound fine-needle aspiration characteristics of primary adenocarcinoma versus other malignant neoplasms of the pancreas. Can J Gastroenterol 2012;26:691-6.
12. Xie HB, Cornwe l l R, Grossman JE, Hoerl HD, Kurtycz DF. Bronchoscopy-guided transtracheal and transbronchial fine-needle aspiration biopsy: A 5-year institutional review of 111 cases. Diagn Cytopathol 2002;27:276-81.
13. Karim Z, Walker B, Lam E. Lymphoepithelial cysts of the pancreas: The use of endoscopic ultrasound-guided fine-needle aspiration in diagnosis. Can J Gastroenterol 2010;24:348-50.
14. Rösch T, Hofrichter K, Frimberger E, Meining A, Born P, Weigert N, et al. ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest Endosc 2004;60:390-6.
15. Wiersema MJ, Vilmann P. EUS-guided FNAB. Gastrointest Endosc 1997;45:243-50.
16. Reddy N, Wilcox CM, Tamhane A, Eloubeidi MA, Varadarajulu S. Protocol-based medical management of post-ERCP pancreatitis. J Gastroenterol Hepatol 2008;23:385-92.
17. Del Chiaro M, Verbeke C, Salvia R, Klöppel G, Werner J, McKay C, et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis 2013;45:703-11.
18. Farrell JJ, Fernandez-Del Castillo C. Pancreatic cystic neoplasms: Management and unanswered questions. Gastroenterology 2013;144:1303-15.
19. Lee LS, Saltzman JR, Bounds BC, Poneros JM, Brugge WR, Thompson CC. EUS-guided fine needle aspiration of pancreatic cysts: A retrospective analysis of complications and their predictors. Clin Gastroenterol Hepatol 2005;3:231-6.
20. Eloubeidi MA, Tamhane A. EUS-guided FNA of solid pancreatic masses: A learning curve with 300 consecutive procedures. Gastrointest Endosc 2005;61:700-8.
21. Eloubeidi MA, Chen VK, Jhala NC, Eltoum IE, Jhala D, Chhieng DC, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2004;2:209-13.
22. Klapman JB, Logrono R, Dye CE, Waxman I. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003;98:1289-94.
23. Moparty B, Logroño R, Nealon WH, Waxman I, Raju GS, Pasricha PJ, et al. The role of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in distinguishing pancreatic cystic lesions. Diagn Cytopathol 2007;35:18-25.
24. Eloubeidi MA, Tamhane A, Varadarajulu S, Wilcox CM. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: A prospective evaluation. Gastrointest Endosc 2006;63:622-9.
25. Trikudanathan G, Navaneethan U, Vege SS. Modern treatment of patients with chronic pancreatitis. Gastroenterol Clin North Am 2012;41:63-76.
26. Erickson RA, Garza AA. EUS with EUS-guided fine-needle aspiration as the first endoscopic test for the evaluation of obstructive jaundice. Gastrointest Endosc 2001;53:475-84.
27. Sugumar A. Diagnosis and management of autoimmune pancreatitis. Gastroenterol Clin North Am 2012;41:9-22.
28. Basturk O, Coban I, Adsay NV. Pancreatic cysts: Pathologic classification, differential diagnosis, and clinical implications. Arch Pathol Lab Med 2009;133:423-38.
29. Nasr J, Sanders M, Fasanella K, Khalid A, McGrath K. Lymphoepithelial cysts of the pancreas: An EUS case series. Gastrointest Endosc 2008;68:170-3.
30. Maitra A, Kern SE, Hruban RH. Molecular pathogenesis of pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:211-26.
31. Hruban RH, Adsay NV. Molecular classification of neoplasms of the pancreas. Hum Pathol 2009;40:612-23.
32. Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 2000;60:2002-6.
33. Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandez-Del Castillo C. Serous cystadenoma of the pancreas: Tumor growth rates and recommendations for treatment. Ann Surg 2005;242:413-9.
34. Brandwein SL, Farrell JJ, Centeno BA, Brugge WR. Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointest Endosc 2001;53:722-7.
35. Ito T, Igarashi H, Jensen RT. Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): Recent insights and advances. J Gastroenterol 2012;47:941-60.
36. Syversen U, Ramstad H, Gamme K, Qvigstad G, Falkmer S, Waldum HL. Clinical significance of elevated serum chromogranin a levels. Scand J Gastroenterol 2004;39:969-73.
37. Klimstra DS. Pathology reporting of neuroendocrine tumors: Essential elements for accurate diagnosis, classification, and staging. Semin Oncol 2013;40:23-36.
38. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: A review of nomenclature, grading, and staging systems. Pancreas 2010;39:707-12.
39. Couvelard A, Deschamps L, Ravaud P, Baron G, Sauvanet A, Hentic O, et al. Heterogeneity of tumor prognostic markers: A reproducibility study applied to liver metastases of pancreatic endocrine tumors. Mod Pathol 2009;22:273-81.
40. Yang Z, Tang LH, Klimstra DS. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: Implications for prognostic stratification. Am J Surg Pathol 2011;35:853-60.
41. Kulke MH, Benson AB 3rd, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, et al. Neuroendocrine tumors. J Natl Compr Canc Netw 2012;10:724-64.
42. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Neuroendocrine Tumors V.2.2014. National Comprehensive Cancer Network, Inc.; 2013. All rights reserved. [Last accessed on 2013 Dec 20]. To view the most recent and complete version of the guideline, go online to www.nccn.org.http://www.nccn.org/ professionals/physician-gls/f- guidelines.asp#neuroendocrine.
43. Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004;80:394-424.
44. Fisher W, Andersen D, Bell R, Saluja A. Pancreas. In: Brunicardi C, editor. Schwartz's Principles of Surgery. 9th ed. New York: McGraw-Hill; 2010. p. 1217-37.
45. Abraham SC, Klimstra DS, Wilentz RE, Yeo CJ, Conlon K, Brennan M, et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 2002;160:1361-9.
46. Tanaka M, Fernandez-Del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-97.
47. Pitman MB, Genevay M, Yaeger K, Chebib I, Turner BG, Mino-Kenudson M, et al. High-grade atypical epithelial cells in pancreatic mucinous cysts are a more accurate predictor of malignancy than 'positive' cytology. Cancer Cytopathol 2010;118:434-40.
48. Mino-Kenudson M, Fernandez-Del Castillo C, Baba Y, Valsangkar NP, Liss AS, Hsu M, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 2011;60:1712-20.
49. Pitman MB. Revised international consensus guidelines for the management of patients with mucinous cysts. Cancer Cytopathol 2012;120:361-5.
50. Pitman MB, Lewandrowski K, Shen J, Sahani D, Brugge W, Fernandez-Del Castillo C. Pancreatic cysts: Preoperative diagnosis and clinical management. Cancer Cytopathol 2010;118:1-13.
51. Eltoum IA, Eloubeidi MA, Chhieng DC, Tamhane A, Crowe R, Jhala D, et al. Cytologic grade independently predicts survival of patients with pancreatic adenocarcinoma. Am J Clin Pathol 2005;124:697-707.
52. Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J. Preoperative/ neoadjuvant therapy in pancreatic cancer: A systematic review and meta-Analysis of response and resection percentages. PLoS Med 2010;7:e1000267.
53. Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB 3rd, Casper ES, et al. Pancreatic Adenocarcinoma, version 2.2012. J Natl Compr Canc Netw 2012; 10:703-713.
54. Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 2012;36:173-84.
55. Roland CL, Bian A, Mansour JC, Yopp AC, Balch GC, Sharma R, et al. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. J Surg Oncol 2012;105:595-600.
56. Pancreatric Section, British Society of Gastroenterology, Pancreatic Society of Great Britain and Ireland, Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, Royal College of Pathologists, Special Interest Group for Gastro-Intestinal Radiology. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut 2005;54 Suppl 5:v1-16.
57. Yamaguchi K, Tanaka M. Committee for Revision of Clinical Guidelines for Pancreatic Cancer of Japan Pancreas Society. EBM-based Clinical Guidelines for Pancreatic Cancer 2009 from the Japan Pancreas Society: A synopsis. Jpn J Clin Oncol 2011;41:836-40.